Generation Bio Co.
GBIO
$6.35
$0.223.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.40% | 80.14% | 39.23% | 45.83% | 34.23% |
| Total Depreciation and Amortization | -10.21% | -13.41% | -11.25% | -8.74% | -3.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.29% | -96.32% | 53.58% | -28.62% | -18.22% |
| Change in Net Operating Assets | 131.98% | 1.24% | -116.10% | -454.34% | -111.01% |
| Cash from Operations | 21.86% | 10.53% | 36.81% | 21.49% | -186.81% |
| Capital Expenditure | -3,178.57% | 87.17% | 91.75% | 85.08% | 99.04% |
| Sale of Property, Plant, and Equipment | 96.15% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.72% | 132.45% | 2,548.72% | 149.10% | -53.61% |
| Cash from Investing | 23.66% | 634.72% | 3,772.10% | 147.80% | -50.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -69.43% | -- | -11.73% | -- | -27.79% |
| Repurchase of Common Stock | 96.77% | 94.40% | 88.03% | 87.79% | 73.73% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -65.81% | 94.40% | 87.01% | 97.71% | 136.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.49% | 21.51% | 303.78% | 86.74% | -118.68% |